UIM
BSX icon

USS Investment Management’s Boston Scientific BSX Stock Holding History

USS Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6M Buy
318,102
+49,071
+18% +$2.66M 0.05% 234
2026
Q1 		$16.9M Buy
269,031
+11,950
+5% +$956K 0.07% 156
2025
Q4 		$24.5M Buy
257,081
+200
+0.1% +$19.6K 0.11% 107
2025
Q3 		$25.1M Hold
256,881
– – 0.11% 104
2025
Q2 		$27.6M Buy
256,881
+2,383
+0.9% +$241K 0.16% 81
2025
Q1 		$25.7M Hold
254,498
– – 0.19% 80
2024
Q4 		$22.7M Sell
254,498
-19,427
-7% -$1.71M 0.16% 108
2024
Q3 		$23M Sell
273,925
-13,394
-5% -$1.06M 0.17% 105
2024
Q2 		$22.1M Buy
287,319
+6,656
+2% +$487K 0.18% 97
2024
Q1 		$19.2M Buy
280,663
+14,459
+5% +$930K 0.16% 118
2023
Q4 		$15.4M Sell
266,204
-45,934
-15% -$2.45M 0.14% 127
2023
Q3 		$16.5M Buy
312,138
+17,508
+6% +$918K 0.18% 115
2023
Q2 		$15.9M Hold
294,630
– – 0.19% 116
2023
Q1 		$14.7M Buy
294,630
+2,678
+0.9% +$126K 0.2% 114
2022
Q4 		$13.5M Sell
291,952
-19,090
-6% -$827K 0.19% 119
2022
Q3 		$12.1M Sell
311,042
-90,407
-23% -$3.63M 0.18% 122
2022
Q2 		$15M Buy
401,449
+23,216
+6% +$945K 0.15% 143
2022
Q1 		$16.8M Buy
378,233
+36,852
+11% +$1.6M 0.14% 159
2021
Q4 		$14.5M Hold
341,381
– – 0.11% 184
2021
Q3 		$14.8M Buy
341,381
+226,038
+196% +$10M 0.13% 167
2021
Q2 		$4.93M Hold
115,343
– – 0.04% 260
2021
Q1 		$4.46M Hold
115,343
– – 0.04% 263
2020
Q4 		$4.14M Hold
115,343
– – 0.04% 249
2020
Q3 		$4.41M Buy
115,343
+2,778
+2% +$107K 0.04% 228
2020
Q2 		$3.95M Buy
+112,565
New +$4.05M 0.04% 239
2013
Q4 		– Sell
-6,912,764
Closed -$81.2M – 75
2013
Q3 		$81.2M Hold
6,912,764
– – 1.52% 20
2013
Q2 		$64.1M Buy
+6,912,764
New +$58.6M 1.37% 31

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

USS Investment Management's BSX Position: Q2 2026 in Review

USS Investment Management increased its Boston Scientific (BSX) stake by 18% in Q2 2026, buying an estimated $2.66M and bringing the position to 318,102 shares worth $13.6M. The position accounts for 0.05% of the portfolio, ranked #234.

USS Investment Management first reported a position in BSX in Q2 2013 and has held it in 27 quarters since. The position peaked at $81.2M in Q3 2013. 1,479 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • USS Investment Management held 318,102 shares of Boston Scientific worth $13.6M as of Q2 2026.
  • USS Investment Management bought 49,071 Boston Scientific shares in Q2 2026, an estimated $2.66M.
  • Boston Scientific made up 0.05% of USS Investment Management's portfolio in Q2 2026, its #234 holding.
  • USS Investment Management first reported a position in Boston Scientific in Q2 2013 and has held it in 27 quarters since.
  • USS Investment Management's Boston Scientific position peaked at $81.2M in Q3 2013.
  • 1,479 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.